Bonviva 150mg Tablets contain ibandronic acid, a bisphosphonate that helps slow bone loss by inhibiting osteoclast-mediated bone resorption. Regular treatment increases bone mineral density and helps reduce the risk of vertebral fractures in postmenopausal women with osteoporosis.
The 150 mg tablet is taken once monthly, making it a convenient option for long-term osteoporosis management. Treatment should be combined with adequate calcium and vitamin D intake where appropriate and regular weight-bearing exercise. Based on clinical guidelines, fracture risk should be reassessed periodically during long-term therapy.
Key Benefits
- Helps strengthen bones
- Reduces the risk of vertebral fractures
- Increases bone mineral density
- Convenient once-monthly dosing
- Supports long-term osteoporosis management
Uses
- Treatment of osteoporosis in postmenopausal women at increased risk of fracture.
Active Ingredients
- Ibandronic acid (ibandronate) 150 mg
How to Take
- Take one tablet once every month on the same date each month.
- Take first thing in the morning with a full glass of plain water.
- Take at least 60 minutes before food, drinks (other than water), or other medicines.
- Swallow the tablet whole and remain upright (sitting or standing) for at least 60 minutes after taking it.
Precautions
- Prescription-only medicine.
- Do not take if you have abnormalities of the oesophagus that delay emptying or if you cannot remain upright for at least 60 minutes.
- Correct low blood calcium before starting treatment.
- Maintain adequate calcium and vitamin D intake.
- Inform your healthcare provider if you develop jaw pain, severe bone pain, or swallowing difficulties.
